51.5 F
Laguna Hills
Thursday, Mar 28, 2024
-Advertisement-

J & J; Profit Up, Mulls Guidant Options

Johnson & Johnson on Tuesday said its third-quarter earnings rose on strong demand for its medical devices, including its Cypher stent, but sales of prescription drugs fell amid competition from cheaper generics.


*For more on this story,

read the full Reuters article.

The company also said its considering alternatives to its planned $25.4 billion buy of Guidant Corp., although it expects regulatory approval this month for the deal.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-